Delve into dermatology diseases with new approaches from conventional to complementary care.
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Expert led instruction for every level of patient care.
Log in to see enrolled program content.
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
The largest integrative dermatology community.
Preview what you'll learn in this program
Description:
This session will review the clinical presentation and severity grading of HS. The decision between topical and systemic therapies will be reviewed and the clinical evidence for TNF, JAK, and IL-17/23 inhibition will be discussed.


Description:
This session will review the clinical presentation and severity grading of HS. The decision between topical and systemic therapies will be reviewed and the clinical evidence for TNF, JAK, and IL-17/23 inhibition will be discussed.
Enroll now to start the course and unlock all learning materials
Complete the previous section to unlock this lesson
Join the conversation with fellow learners



